Question 1

What specific symptoms of schizophrenia might linagliptin help improve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Linagliptin in Schizophrenia Patients clinical trial (NCT01943019). Contact the study team or your healthcare provider for specific answers.

Question 2

How does linagliptin compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Linagliptin in Schizophrenia Patients clinical trial (NCT01943019). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of linagliptin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Linagliptin in Schizophrenia Patients clinical trial (NCT01943019). Contact the study team or your healthcare provider for specific answers.

Question 4

How long would I need to participate in the trial, and how often would I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Linagliptin in Schizophrenia Patients clinical trial (NCT01943019). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my symptoms worsen during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Linagliptin in Schizophrenia Patients clinical trial (NCT01943019). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Linagliptin in Schizophrenia Patients clinical trial (NCT01943019). Contact the study team or your healthcare provider for specific answers.

What this study is about